Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants

Background. KL-6 is a biomarker of interstitial lung injury and increases during repair. Aim. Our aim was to determine the predictive value of plasma KL-6 for the development of bronchopulmonary dysplasia (BPD) in preterm infants. Methods. Ninety-five extremely preterm infants (EPIs), born at <28...

Full description

Bibliographic Details
Main Authors: Petya Radulova, Margaritka Boncheva, Gencho Nachev, Boriana Slancheva, Violeta Dimitrova
Format: Article
Language:English
Published: Hindawi Limited 2024-01-01
Series:Critical Care Research and Practice
Online Access:http://dx.doi.org/10.1155/2024/3623948
_version_ 1797322537680502784
author Petya Radulova
Margaritka Boncheva
Gencho Nachev
Boriana Slancheva
Violeta Dimitrova
author_facet Petya Radulova
Margaritka Boncheva
Gencho Nachev
Boriana Slancheva
Violeta Dimitrova
author_sort Petya Radulova
collection DOAJ
description Background. KL-6 is a biomarker of interstitial lung injury and increases during repair. Aim. Our aim was to determine the predictive value of plasma KL-6 for the development of bronchopulmonary dysplasia (BPD) in preterm infants. Methods. Ninety-five extremely preterm infants (EPIs), born at <28 gestational age (GA), were divided into two main BPD groups as follows: the moderate/severe and the no/mild group. KL-6 was analyzed on days 7 and 14. Binary logistic regression analyses and ROC curve analyses were performed. Results. Infants <26 + 0 weeks’ GA have higher mean KL-6 than infants >25 + 6 weeks’ GA on 7 and 14 days (335 vs. 286 U/ml and 378 vs. 260 U/ml; p=0.005 and 0.018, respectively). In the binary regression model at KL-6 day 7, three of the prognostic factors remained significant—mechanical ventilation OR: 10.38 (95% CI: 3.57–30.14), PDA OR: 6.39 (95% CI: 0.87–46.74), and KL-6 OR: 4.98 (95% CI: 1.54–16.08). The AUC was 0.86 with a sensitivity and specificity of 79% at a cutoff value ≥0.34. In the binary regression model at KL-6 day 14, six of the prognostic factors were significant—PDA OR: 23.34 (95% CI: 2.14–254.24), KL-6 OR: 13.59 (95% CI: 3.19–57.96), GA OR: 4.58 (95% CI: 1.16–18.06), mechanical ventilation OR: 4.45 (95% CI: 1.23–16.16), antenatal steroids OR: 0.19 (95% CI: 0.04–0.95), and gender (female OR: 0.30 (95% CI 0.08–1.12)). The AUC was 0.91, and the sensitivity and accuracy for a cutoff ≥0.37 were 89% and 85%, respectively. Conclusion. KL-6 could be a useful screening biomarker for early detection of infants at increased risk for developing BPD.
first_indexed 2024-03-08T05:15:44Z
format Article
id doaj.art-0a849a7b348b4721b7a50d0390de6e5f
institution Directory Open Access Journal
issn 2090-1313
language English
last_indexed 2024-03-08T05:15:44Z
publishDate 2024-01-01
publisher Hindawi Limited
record_format Article
series Critical Care Research and Practice
spelling doaj.art-0a849a7b348b4721b7a50d0390de6e5f2024-02-07T00:00:11ZengHindawi LimitedCritical Care Research and Practice2090-13132024-01-01202410.1155/2024/3623948Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm InfantsPetya Radulova0Margaritka Boncheva1Gencho Nachev2Boriana Slancheva3Violeta Dimitrova4Department of Obstetrics and GynecologyUniversity Hospital for Active Treatment “St. Ekaterina”University Hospital for Active Treatment “St. Ekaterina”Department of Obstetrics and GynecologyDepartment of Obstetrics and GynecologyBackground. KL-6 is a biomarker of interstitial lung injury and increases during repair. Aim. Our aim was to determine the predictive value of plasma KL-6 for the development of bronchopulmonary dysplasia (BPD) in preterm infants. Methods. Ninety-five extremely preterm infants (EPIs), born at <28 gestational age (GA), were divided into two main BPD groups as follows: the moderate/severe and the no/mild group. KL-6 was analyzed on days 7 and 14. Binary logistic regression analyses and ROC curve analyses were performed. Results. Infants <26 + 0 weeks’ GA have higher mean KL-6 than infants >25 + 6 weeks’ GA on 7 and 14 days (335 vs. 286 U/ml and 378 vs. 260 U/ml; p=0.005 and 0.018, respectively). In the binary regression model at KL-6 day 7, three of the prognostic factors remained significant—mechanical ventilation OR: 10.38 (95% CI: 3.57–30.14), PDA OR: 6.39 (95% CI: 0.87–46.74), and KL-6 OR: 4.98 (95% CI: 1.54–16.08). The AUC was 0.86 with a sensitivity and specificity of 79% at a cutoff value ≥0.34. In the binary regression model at KL-6 day 14, six of the prognostic factors were significant—PDA OR: 23.34 (95% CI: 2.14–254.24), KL-6 OR: 13.59 (95% CI: 3.19–57.96), GA OR: 4.58 (95% CI: 1.16–18.06), mechanical ventilation OR: 4.45 (95% CI: 1.23–16.16), antenatal steroids OR: 0.19 (95% CI: 0.04–0.95), and gender (female OR: 0.30 (95% CI 0.08–1.12)). The AUC was 0.91, and the sensitivity and accuracy for a cutoff ≥0.37 were 89% and 85%, respectively. Conclusion. KL-6 could be a useful screening biomarker for early detection of infants at increased risk for developing BPD.http://dx.doi.org/10.1155/2024/3623948
spellingShingle Petya Radulova
Margaritka Boncheva
Gencho Nachev
Boriana Slancheva
Violeta Dimitrova
Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
Critical Care Research and Practice
title Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
title_full Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
title_fullStr Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
title_full_unstemmed Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
title_short Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants
title_sort plasma kl 6 as a potential biomarker for bronchopulmonary dysplasia in preterm infants
url http://dx.doi.org/10.1155/2024/3623948
work_keys_str_mv AT petyaradulova plasmakl6asapotentialbiomarkerforbronchopulmonarydysplasiainpreterminfants
AT margaritkaboncheva plasmakl6asapotentialbiomarkerforbronchopulmonarydysplasiainpreterminfants
AT genchonachev plasmakl6asapotentialbiomarkerforbronchopulmonarydysplasiainpreterminfants
AT borianaslancheva plasmakl6asapotentialbiomarkerforbronchopulmonarydysplasiainpreterminfants
AT violetadimitrova plasmakl6asapotentialbiomarkerforbronchopulmonarydysplasiainpreterminfants